BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10767366)

  • 1. Intermittent adjuvant chemo-immunotherapy after resection of non-small cell lung cancer with multilevel mediastinal lymph node metastasis.
    Suzuki M; Kimura H; Iwai N; Fujisawa T
    Oncol Rep; 2000; 7(3):545-9. PubMed ID: 10767366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer.
    Kimura H; Yamaguchi Y
    Lung Cancer; 1995 Aug; 13(1):31-44. PubMed ID: 8528638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment of non-small cell lung cancer with mediastinal node invasion. A retrospective study].
    Arnau Obrer A; Martín Díaz E; Pérez Alonso D; Regueiro Mira F; Cervera Juan A; Granell Gil M; Roch Pendería S; Cantó Armengod A
    Arch Bronconeumol; 2001 Mar; 37(3):121-6. PubMed ID: 11333537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemo-immunotherapy after curative resection of Stage II and IIIA primary lung cancer.
    Kimura H; Yamaguchi Y
    Lung Cancer; 1996 Jun; 14(2-3):301-14. PubMed ID: 8794412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304).
    Tada H; Tsuchiya R; Ichinose Y; Koike T; Nishizawa N; Nagai K; Kato H
    Lung Cancer; 2004 Feb; 43(2):167-73. PubMed ID: 14739037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective phase II study of post-surgical adjuvant chemo-immunotherapy using autologous dendritic cells and activated killer cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients.
    Kimura H; Iizasa T; Ishikawa A; Shingyouji M; Yoshino M; Kimura M; Inada Y; Matsubayashi K
    Anticancer Res; 2008; 28(2B):1229-38. PubMed ID: 18505060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations.
    Okada M; Tsubota N; Yoshimura M; Miyamoto Y; Matsuoka H
    Chest; 2000 Jul; 118(1):123-8. PubMed ID: 10893369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgery and combined therapy for non-small cell lung cancer with invasion of the mediastinal nodes. A retrospective study].
    Arnau Obrer A; Martín Díaz E; Pérez Alonso D; Regueiro Mira F; Cañizares Carretero M; Cervera Juan A; Granell Gil M; Roch Tejerina S; Cantó Armengod A
    Arch Bronconeumol; 2001 Apr; 37(4):160-5. PubMed ID: 11412499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
    Saka H; Kitagawa C; Ichinose Y; Takenoyama M; Ibata H; Kato T; Takami K; Yamashita M; Maeda T; Takeo S; Ueda H; Okabayashi K; Nagashima S; Oka T; Kouso H; Fukuyama S; Yoshimoto K; Shimokawa M; Saito AM; Ito S
    Trials; 2017 Sep; 18(1):429. PubMed ID: 28915900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of adjuvant therapy in the management of pN2 non-small-cell carcinoma of the lung].
    Chella A; Lucchi M; Gragnani F; Ribechini A; Silvano G; Janni A; Mussi A; Angeletti CA
    Minerva Chir; 1995 Dec; 50(12):1029-38. PubMed ID: 8725059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
    Wada H; Miyahara R; Tanaka F; Hitomi S
    Eur J Cardiothorac Surg; 1999 Apr; 15(4):438-43. PubMed ID: 10371118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy.
    Han H; Zhao Y; Gao Z; Zheng D; Fu F; Zhao Z; Tang Y; Xiang J; Sun Y; Hu H; Chen H
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2115-2122. PubMed ID: 31175463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
    Scagliotti GV; Fossati R; Torri V; Crinò L; Giaccone G; Silvano G; Martelli M; Clerici M; Cognetti F; Tonato M;
    J Natl Cancer Inst; 2003 Oct; 95(19):1453-61. PubMed ID: 14519751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended surgical resection in stage III non-small cell lung cancer.
    Hillinger S; Weder W
    Front Radiat Ther Oncol; 2010; 42():115-121. PubMed ID: 19955797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
    Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative adjuvant therapy for stage II non-small-cell lung cancer.
    Park JH; Shim YM; Baek HJ; Kim MS; Choe DH; Cho KJ; Lee CT; Zo JI
    Ann Thorac Surg; 1999 Nov; 68(5):1821-6. PubMed ID: 10585065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy for T4 centrally located non-small cell lung cancer.
    Rendina EA; Venuta F; De Giacomo T; Ciccone AM; Ruvolo G; Coloni GF; Ricci C
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):225-33. PubMed ID: 9918961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of long-term survival in patients with locally advanced non-small cell lung cancer.
    Wagner W; Striehn E; Klinke F; Bosse U; Rübe C
    Oncol Rep; 1998; 5(6):1547-50. PubMed ID: 9769403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.